Homozygous nonsense mutation in helix 2 of K14 causes severe recessive epidermolysis bullosa simplex

We have studied a consanguineous family containing two children with severe, generalized epidermolysis bullosa simplex (EBS). Electron microscopy of skin biopsies from the affected individuals showed that basal keratinocytes were devoid of tonofilament bundles, although some single intermediate filament were visible. Genetic linkage analysis with the microsatellite probe D12S96 excluded the type II keratin gene cluster in this family. However, homozygosity by descent was observed with the polymorphic probes KRT9, KRT10 Ava II, and D17S1787 in both affected children, consistent with a recessive defect in a type I keratin. Immunoreactivity to keratin K5 and K15 was normal, but monoclonal antibodies LL001 and RCK107 against K14 showed no staining, suggesting a deficiency of K14 in these individuals. MRNA extracted from biopsy material was amplified by RT‐PCR to obtain full‐length K14 cDNA. Direct automated sequencing identified a homozygous nonsense mutation, W305X. A Hinf I restriction enzyme site is created by this nucleotide transition, which was used to confirm the presence of the mutation in this kindred and exclude it from 100 normal chromosomes. This is the fourth kindred with severe recessive EBS for whom a mutation has been found in the K14 gene. In this instance, the premature termination codon is the farthest downstream of the reported cases, occurring in the helix 2 domain and so giving a much longer translation product. Nevertheless, the heterozygous carriers are unaffected by the disease and display no epidermal fragility. We postulate that translation of the potentially dominant‐negative truncated K14 might be down‐regulated due to instability of the mutant mRNA, as observed in previous cases with similar mutations. Hum Mutat 11:279–285, 1998.© 1998 Wiley‐Liss, Inc.

[1]  Jonathan E. Moore,et al.  Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy , 1997, Nature Genetics.

[2]  W. McLean,et al.  Human keratin diseases: , 1996, Experimental dermatology.

[3]  H. Scheffer,et al.  Effects of keratin 14 ablation on the clinical and cellular phenotype in a kindred with recessive epidermolysis bullosa simplex. , 1996, The Journal of investigative dermatology.

[4]  E. Epstein The genetics of human skin diseases. , 1996, Current opinion in genetics & development.

[5]  M. Blumenberg,et al.  Close linkage of the two keratin gene clusters in the human genome. , 1996, Genomics.

[6]  D. Melton,et al.  Gene targeting at the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin expression in the epidermis , 1996, The Journal of cell biology.

[7]  E. Fuchs,et al.  The basal keratin network of stratified squamous epithelia: defining K15 function in the absence of K14 , 1995, The Journal of cell biology.

[8]  E. Lane,et al.  Keratin 16 and keratin 17 mutations cause pachyonychia congenita , 1995, Nature Genetics.

[9]  S. Peltz,et al.  Identification and characterization of genes that are required for the accelerated degradation of mRNAs containing a premature translational termination codon. , 1995, Genes & development.

[10]  R. Kucherlapati,et al.  Organization of the human keratin type II gene cluster at 12q13. , 1994, Genomics.

[11]  E. Fuchs,et al.  A human keratin 14 "knockout": the absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein. , 1994, Genes & development.

[12]  E. Lane,et al.  A functional "knockout" of human keratin 14. , 1994, Genes & development.

[13]  J. Lavergne,et al.  Human Gene Mutation , 1994 .

[14]  Y. Barrandon,et al.  A missense mutation in the rod domain of keratin 14 associated with recessive epidermolysis bullosa simplex , 1993, Nature Genetics.

[15]  K. Owaribe,et al.  HD4, a 180 kDa bullous pemphigoid antigen, is a major transmembrane glycoprotein of the hemidesmosome. , 1993, Journal of biochemistry.

[16]  D. Cooper,et al.  Human gene mutations affecting RNA processing and translation. , 1993, Annals of medicine.

[17]  E. Lane,et al.  AvaII RFLP of human keratin 10 (KRT-10) detected by PCR. , 1992, Human molecular genetics.

[18]  S. Bale,et al.  A leucine→proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis , 1992, Cell.

[19]  D. Ward,et al.  In situ hybridization to the crithidia fasciculata kinetoplast reveals two antipodal sites involved in kinetoplast DNA replication , 1992, Cell.

[20]  E. Lane,et al.  Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma). , 1992, The Journal of investigative dermatology.

[21]  E. Lane,et al.  A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering , 1992, Nature.

[22]  F. Smedts,et al.  Basal-cell keratins in cervical reserve cells and a comparison to their expression in cervical intraepithelial neoplasia. , 1992, The American journal of pathology.

[23]  Alana L. Rothman,et al.  Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. , 1991, Science.

[24]  Elaine Fuchs,et al.  Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: Genetic and functional analyses , 1991, Cell.

[25]  E. Fuchs,et al.  Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease , 1991, Cell.

[26]  E. Fuchs,et al.  Deletions in epidermal keratins leading to alterations in filament organization in vivo and in intermediate filament assembly in vitro , 1990, The Journal of cell biology.

[27]  E. Lane,et al.  Antibody markers of basal cells in complex epithelia. , 1990, Journal of cell science.

[28]  E. Lane,et al.  Retrovirus-mediated transgenic keratin expression in cultured fibroblasts: Specific domain functions in keratin stabilization and filament formation , 1990, Cell.

[29]  T. Sun,et al.  Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas , 1989, Virchows Archiv. B, Cell pathology including molecular pathology.

[30]  W. Franke,et al.  Spontaneous losses of control of cytokeratin gene expression in transformed, non-epithelial human cells occurring at different levels of regulation , 1989, Cell.

[31]  D. Kulesh,et al.  Posttranslational regulation of keratins: degradation of mouse and human keratins 18 and 8 , 1989, Molecular and cellular biology.

[32]  J. Jorcano,et al.  Synthesis and fate of keratins 8 and 18 in nonepithelial cells transfected with cDNA. , 1988, Experimental cell research.

[33]  J. Ortonne,et al.  Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes. , 1987, Experimental cell research.

[34]  E. Fuchs,et al.  Complete sequence of a gene encoding a human type I keratin: sequences homologous to enhancer elements in the regulatory region of the gene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. D. Goldman,et al.  Intermediate filaments , 1984, The Journal of cell biology.

[36]  Benjamin Geiger,et al.  The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.

[37]  M. Omary,et al.  Mutation of human keratin 18 in association with cryptogenic cirrhosis. , 1997, The Journal of clinical investigation.

[38]  E. Bauer,et al.  Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. , 1991, Journal of the American Academy of Dermatology.

[39]  M. Blumenberg,et al.  Inactivation of human keratin genes: the spectrum of mutations in the sequence of an acidic keratin pseudogene. , 1988, Molecular biology and evolution.